Whole genome sequencing indicated that both the OS biopsy at initial diagnosis and the TT2-77 PDX generated from a tumor specimen obtained at resection three years later harbor the MYC-RAD21+ signature (original biopsy and TT2-77 PDX = 4 copies per amplicon, Table S7). The gene discussed is RAD21; the disease is neoplasm.